|
Sample Responses:
C. Lay Description:
Paraplegia (paralysis of the legs) is a major and devastating
complication following surgery on the aorta (the major artery of the
body). All patients undergoing such operations are at risk for
becoming paralyzed. Operations for repair of the aorta necessitate
temporary interruption of blood flow through the artery and this can
lead to inadequate supply to the spinal cord (which controls leg
movements). The mechanism of the injury to the spinal cord is not
clearly understood, although there are several treatments that seem
to protect (with limited success) the spinal cord from this
injury.
Recent evidence has shown that glutamate (normally found in small
amounts in the spinal cord) is released in large quantities during
interruption of the blood supply and leads to damage and death of
cells within the spinal cord. Glutamate causes damage by attaching to
receptors on the nerve cells. New drugs called "Glutamate
Antagonists" can be used to block the receptors before the glutamate
is released, so it cannot attach to the cells. These drugs also
prevent the release of glutamate by an unknown mechanism. Although
these drugs have shown activity against glutamate in cultured cells,
they have never been tested to see if they can prevent the damage to
the spinal cord seen with surgery on the aorta.
We propose to study the effectiveness of one of these drugs,
dextrorphan, on the protecting the spinal cord in a rabbit model. The
rabbit is an excellent model for simulating aortic operations and the
paraplegia associated with these operations. Some groups of animals
will undergo surgery without giving dextrorphan and some will undergo
surgery and receive dextrorphan during surgery. After the operation,
each rabbit will receive pain medications for at least two days. The
rabbits will be evaluated on their ability to stand and hop for the
next 4 days. Differences between the treated and untreated groups
will be measured. After the observation period, the rabbits will be
euthanized and the spinal cords removed for other measurements.
D. Rationale:
i. What is the scientific background that underlies the
approach taken (including literature citations)?
The goal of this project is to determine if Mouse Hepatitis Virus
(MHV) can be given intranasally to produce lesions causing dysosmia
in Swiss-Webster mice without causing systemic disease. Ideally, this
dysosmia will be measurable by the Olfactory Confusion Matrix (OCM)
testing system developed in our laboratory (Youngentob et al., 1990).
In order for animals to be suitable for OCM system, they must recover
from the infection and have no other impairments except for dysosmia.
Therefore, the hepatitis strain selected should not cause acute or
chronic liver disease from which there is no recovery. There is a
great deal of information on MHV and its effect on different
genotypes of mice (Barhold, et al., 1986). Unfortunately, the
information is then where the older Swiss-Webster mouse is concerned.
However, these are the only mice suitable for the OCM system due to
their size (see "specific study" section C). To determine the
efficacy of the virus to produce the desired results, we will assay
several parameters: 1) clinical observation -after intranasal
infection, animals will be observed for 30 days. During the
observation period, animals will be weighed and monitored for signs
of illness daily. Any animal which becomes moribund will be
euthanized and have a histopathological examination to determine
extent of disease. 2) pathologic changes - after intranasal
inoculation, animals will be euthanized at various timepoints and the
brains and nasal tracts studied for pathological changes using
biochemical techniques, light microscopy and electron microscopy
(Schwob, JE et al.,1992). In addition, a recording of odorant-induced
mucosal activity patterns will be made (Kent, PF et al., 1992).
Barthold, SW, et al: Mouse hepatitis virus nasoencephalopathy is
dependent upon virus strain and host genotype. Arch Virol 1986;
91:247-256.
Kent, PF and Mozell, MM: The recording of odorant-induced mucosal
activity patterns with a voltage-sensitive dye. J of Neurophysiol
1992; 68:184-1919.
Schwob, JE, et al: Olfactory sensory neurons are tropically
dependent on the olfactory bulb for their prolonged survival. The
Journal of Neuroscience 1992; 12: 3896-3919.
Youngentob, SL et al: A method for establishing a five odorant
identification confusion matrix task in rats. Physiology and Behavior
1990; 47:1053-1059.
ii. What value or potential contributions to biology or
medicine may come from this work?
One out of every 11 women will be diagnosed with breast cancer at
some point during her lifetime and the incidence appears to be
increasing. Despite these alarming statistics, few attempts have been
made to treat breast cancer patients with adoptive immunotherapy.
Since I have found that significantly higher levels of TIL cells
accumulate in mouse mammary tumors than in corresponding normal
mammary tissue subsequent to adoptive transfer, the TIL may be the
appropriate cell for immunotherapy of breast cancer. If altered TIL
cells can be shown to selectively kill mouse mammary adenocarcinoma
cells, this may lead the way to clinical trials with human TIL cells
in breast cancer patients.
iii. Please give detailed reasons why animals must be used.
Although the induction and inhibition of somatostatin release can
be measured in cultured cells its effect on the gastric phase of
digestion can only be evaluated on a living system. Somatostatin
effects multiple organ systems with feedbacks to gastrointestinal
function. The complex biological interactions involved cannot
currently be duplicated in a computer model or cell culture
system.
iv. Please give detailed reasons why this species must be
used?
The pig is currently the standard model for simulating human
endoscopic abdominal surgery. The organs are of very similar size and
structure to humans, allowing the learning surgeon to train in an
environment most similar to what will be encountered in actual human
surgery. Smaller species would not allow room for the multiple
instruments and access points required for these operations. Pigs are
readily available since they are raised in very large numbers for
commercial food production.
v. Are your using the fewest number of animals possible? Please
explain.* Include the number of groups with the "n" value for animals
clearly outlined.
· A guideline that is sometimes appropriate
is that the sample size should be adequate to detect reliably a 10%
difference in treatment means. If not statistically justifiable,
please justify the number of animals to be used or indicate that this
is a pilot study designed to demonstrate the amount of variability
expected in the data.
Previous work in this area has demonstrated that an n=8 mice per
group is necessary to demonstrate a statistical difference (p=0.05)
between treatment groups. We propose to study 4 different drugs at
both a high and low dose. Saline will be used as the control. One
group will be needed for each timepoint (5 timepoints), therefore we
need the following:
4 drugs X 2 doses = 8 drug treatment groups + saline = 9
treatment groups.
9 treatment groups X 5 timepoints = 45 groups X 8 mice = 360 mice
total *
OR
All of the experiments proposed in this protocol are performed in
vitro using primary cultured hepatocytes harvested from rats without
prior manipulation. All of the experiments listed in section G will
be undertaken in the next 3 years. Each experiment requires variable
amounts of hepatic cells which are taken from a central "stock
culture" maintained at all times within the laboratory. The stock
culture must be renewed weekly (with any remaining cells discarded)
due to senescence of the cells causing changes in biochemical
properties. It takes 3 livers from neonatal rats to make up the stock
culture and the rats can be used any time in the first two weeks
after birth. Sprague-Dawley rats average about 8 pups per litter.
This means we should be able (with some flexibility in when the
cultures are prepared) get two weeks of stock culture from each
litter. Therefore, we will need 1 pregnant female ever two weeks for
the 3 years of this protocol (1 X 26 X 3 = 78 pregnant rats).
Contamination of the stock culture occurs occasionally (5-10%) and
some litters are too small to get two cultures (5%), so we are
requesting an additional 10% of the required pregnant females (8) to
ensure adequate numbers to maintain our stock culture. Therefore, we
require a total of 86 pregnant female SD rats*.
*Examples note: The total number of animals should always be
consistent throughout the protocol and should be equivalent to the
total number of animals requested in section B.
|